Jeff Jonas

1 result

Merck’s total sales rose 5.4 per cent to $10.47 billion but  investors  expected bigger gains in market share for the cancer therapy. Photograph: Ralph Orlowski/Reuters

Merck & Co beat quarterly profit estimates on Friday as sales of its blockbuster drug Keytruda overtook rival Bristol-Myers Squibb’s Opdivo, but t(...)